Itau Unibanco Holding S.A.’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-583
Closed -$8.17K 579
2023
Q1
$8.17K Hold
583
﹤0.01% 461
2022
Q4
$8.34K Sell
583
-46
-7% -$724 ﹤0.01% 469
2022
Q3
$16K Hold
629
﹤0.01% 465
2022
Q2
$18K Sell
629
-30
-5% -$950 ﹤0.01% 400
2022
Q1
$23K Hold
659
﹤0.01% 373
2021
Q4
$28K Buy
659
+224
+51% +$9.07K ﹤0.01% 350
2021
Q3
$21K Buy
435
+11
+3% +$537 ﹤0.01% 333
2021
Q2
$18K Buy
+424
New +$16.4K ﹤0.01% 308

Other funds holding MRVI

Itau Unibanco Holding S.A.'s MRVI Position: Q2 2023 in Review

Itau Unibanco Holding S.A. sold out of Maravai LifeSciences (MRVI) in Q2 2023, closing a stake of 583 shares — an estimated $8.17K sold.

Itau Unibanco Holding S.A. first reported a position in MRVI in Q2 2021 and held it in 8 quarters. The position peaked at $28K in Q4 2021. 221 funds tracked by Wall St. Rank hold MRVI as of Q2 2023.

  • Itau Unibanco Holding S.A. reported no remaining Maravai LifeSciences position as of Q2 2023 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 583 Maravai LifeSciences shares in Q2 2023, an estimated $8.17K.
  • Itau Unibanco Holding S.A. first reported a position in Maravai LifeSciences in Q2 2021 and held it in 8 quarters.
  • Itau Unibanco Holding S.A.'s Maravai LifeSciences position peaked at $28K in Q4 2021.
  • 221 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2023.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2023, filed 14 Aug 2023.